Pharmafile Logo
Pharmafocus logo
Advanced Search

Microsoft licensing deal to save NHS

November 8, 2004

News

PR: the power of perceptions

November 3, 2004

Pharma is taking an increasing interest in PR and what it can achieve in the marketing mix. But with a …

Feature

Lilly’s Alimta ready for UK launch

November 2, 2004

Lilly's chemotherapy drug Alimta is to be launched in the UK for the treatment of malignant pleural mesothelioma, a type …

News

Mission to maximise

November 2, 2004

We all know that 'less is more'. What clearer mission could you have as a marketer – take this product …

Feature

Black box warning for antidepressants in US

November 2, 2004

The industry's biggest selling antidepressants will all have to carry the strongest possible warnings in the US, after the FDA …

News

Industry ready to reply after critics savage practices

November 2, 2004

UK regulator the MHRA and the pharmaceutical industry have been condemned for being engaged in a closed and uncritical relationship, …

News

Lonngren lashes out at late warning

November 1, 2004
EMA, EMEA, Lonngren, Vioxx

 Thomas Lonngren, the head of Europe’s medicines regulator the EMEA has spoken out about Merck’s withdrawal of Vioxx, saying the …

News

Nanotechnology: small could be big

October 27, 2004

Nanotechnology is starting to fuel the imagination and commercial aspirations of pharma companies, but sound strategies for intellectual property protection …

Feature

Pfizer warns of slowdown in 2005

October 27, 2004

Pfizer has warned that growth in 2005 could be held back by generic competition and other increasing market pressures.The company's …

News

Prexige launch delayed

October 27, 2004

Novartis has delayed the launch of its potential blockbuster painkiller Prexige until 2007, in the wake of Vioxx's withdrawal. The …

News

Landmark pharmacy contract agreed in England and Wales

October 27, 2004

News

Payments by Results blamed for foundation trust trouble

October 27, 2004

News

Cipralex shows fewer side-effects than Efexor

October 25, 2004

Lundbeck says two new studies prove that patients taking its antidepressant Cipralex (escitalopram) gain relief faster and suffer fewer side-effects …

News

Equality champion to tackle NHS diversity agenda

October 21, 2004

The NHS has engaged its first equality and human rights director to head up its diversity agenda. Surinder Sharma has …

News

Non-patronising medicine guides launched

October 21, 2004

News

The fight against fat

October 21, 2004

Feature

Pharmafocus & InPharm Career Survey 2004

October 21, 2004

Feature

Abbott third quarter profits grow as Humira sales soar

October 21, 2004

Abbott Laboratories' third quarter profits grew by 8.7% to $853 million, driven by global sales increases of 10.2%, which were …

News

Buoyant Roche to enter cholesterol market

October 21, 2004

Roche has announced an alliance with a Japanese company to develop and market JTT-705 a promising new treatment for cholesterol.The …

News

Stroke breakthrough buoys UK stem cell company

October 21, 2004

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026